Related News
Home » Metro » Health and Science
Chinese and French team up to fight rare diseases
By Cai Wenjun |
September 28, 2012, Friday
|
Online Edition
Online Edition
China State Institute of Pharmaceutical Industry signed a memorandum of understanding with French pharmaceutical giant Sanofi in Shanghai yesterday to conduct joint research on rare disease diagnosis and treatment in China.
The purpose of the project is to accelerate the translation of research results into new medicines and therapies for rare disease patients in China.
The World Health Organization defines rare disease as diseases with an incidence rate between 0.65 and 1 per 1,000 people. According to statistics from the US National Institute of Health, nearly 7,000 diseases worldwide belong to rare diseases. But China does not yet have an official definition of rare diseases, making it difficult to formulate related policies.
Wang Lifeng, vice chairman of the board of SinoPharm, said Sanofi and its subsidiary Genzyme are well experienced in rare disease treatment.
"Our collaboration with Sanofi aims to define rare disease causes, prevalence and patient distribution in China. This research will allow us to accelerate the development of cures for rare disease patients in China," she said.
The purpose of the project is to accelerate the translation of research results into new medicines and therapies for rare disease patients in China.
The World Health Organization defines rare disease as diseases with an incidence rate between 0.65 and 1 per 1,000 people. According to statistics from the US National Institute of Health, nearly 7,000 diseases worldwide belong to rare diseases. But China does not yet have an official definition of rare diseases, making it difficult to formulate related policies.
Wang Lifeng, vice chairman of the board of SinoPharm, said Sanofi and its subsidiary Genzyme are well experienced in rare disease treatment.
"Our collaboration with Sanofi aims to define rare disease causes, prevalence and patient distribution in China. This research will allow us to accelerate the development of cures for rare disease patients in China," she said.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
